The UK’s first Biograph mMR, a hybrid molecular MR system from Siemens Healthcare, has been delivered to the University College Hospital (UCH) Macmillan Cancer Centre in London.
The next stage of commissioning will now take place with anticipated go-live in spring 2012 when the new center opens its doors to patients.
The Biograph mMR combines the functionality of MR and PET in one integrated technology. The same size of a standard 3T MRI scanner, it acquires MR functional details in human tissue and PET cellular activity in a simultaneous procedure, according to the company. The system will be used in the Cancer Centre for 60 percent routine clinical work and 40 percent research projects, the hospital said.
The UCH Macmillan Cancer Centre is currently entering its final building stages and has been designed for cancer care.